447 related articles for article (PubMed ID: 23553816)
1. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
[TBL] [Abstract][Full Text] [Related]
2. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.
Yahata N; Matsumoto Y; Omi M; Yamamoto N; Hata R
Sci Rep; 2017 Nov; 7(1):15557. PubMed ID: 29138463
[TBL] [Abstract][Full Text] [Related]
3. Modeling of mitochondrial bioenergetics and autophagy impairment in MELAS-mutant iPSC-derived retinal pigment epithelial cells.
Bhattacharya S; Yin J; Huo W; Chaum E
Stem Cell Res Ther; 2022 Jun; 13(1):260. PubMed ID: 35715869
[TBL] [Abstract][Full Text] [Related]
4. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
[TBL] [Abstract][Full Text] [Related]
5. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
[TBL] [Abstract][Full Text] [Related]
6. Intracellular heteroplasmy for disease-associated point mutations in mtDNA: implications for disease expression and evidence for mitotic segregation of heteroplasmic units of mtDNA.
Matthews PM; Brown RM; Morten K; Marchington D; Poulton J; Brown G
Hum Genet; 1995 Sep; 96(3):261-8. PubMed ID: 7649539
[TBL] [Abstract][Full Text] [Related]
7. Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model.
Hämäläinen RH; Manninen T; Koivumäki H; Kislin M; Otonkoski T; Suomalainen A
Proc Natl Acad Sci U S A; 2013 Sep; 110(38):E3622-30. PubMed ID: 24003133
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp).
Hatakeyama H; Katayama A; Komaki H; Nishino I; Goto Y
Acta Neuropathol Commun; 2015 Aug; 3():52. PubMed ID: 26297375
[TBL] [Abstract][Full Text] [Related]
9. Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels.
Kodaira M; Hatakeyama H; Yuasa S; Seki T; Egashira T; Tohyama S; Kuroda Y; Tanaka A; Okata S; Hashimoto H; Kusumoto D; Kunitomi A; Takei M; Kashimura S; Suzuki T; Yozu G; Shimojima M; Motoda C; Hayashiji N; Saito Y; Goto Y; Fukuda K
FEBS Open Bio; 2015; 5():219-25. PubMed ID: 25853038
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Signature of MELAS/Leigh Overlap Syndrome in Patient-specific Induced Pluripotent Stem Cells Model.
Hattori T; Hamazaki T; Kudo S; Shintaku H
Osaka City Med J; 2016 Dec; 62(2):69-76. PubMed ID: 30721581
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Nuclear Retrograde Regulator 1 (MNRR1) rescues the cellular phenotype of MELAS by inducing homeostatic mechanisms.
Aras S; Purandare N; Gladyck S; Somayajulu-Nitu M; Zhang K; Wallace DC; Grossman LI
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32056-32065. PubMed ID: 33257573
[TBL] [Abstract][Full Text] [Related]
12. Establishment of variant free-iPSC (UOMi003-A) line from patient with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes.
Sequiera GL; Rockman-Greenberg C; Dhingra S
Stem Cell Res; 2020 Oct; 48():101935. PubMed ID: 32777772
[TBL] [Abstract][Full Text] [Related]
13. Multimodal single-cell analysis of nonrandom heteroplasmy distribution in human retinal mitochondrial disease.
Mullin NK; Voigt AP; Flamme-Wiese MJ; Liu X; Riker MJ; Varzavand K; Stone EM; Tucker BA; Mullins RF
JCI Insight; 2023 Jul; 8(14):. PubMed ID: 37289546
[TBL] [Abstract][Full Text] [Related]
14. Relationship of genotype to phenotype in fibroblast-derived transmitochondrial cell lines carrying the 3243 mutation associated with the MELAS encephalomyopathy: shift towards mutant genotype and role of mtDNA copy number.
Bentlage HA; Attardi G
Hum Mol Genet; 1996 Feb; 5(2):197-205. PubMed ID: 8824875
[TBL] [Abstract][Full Text] [Related]
15. Oxidative Insults and Mitochondrial DNA Mutation Promote Enhanced Autophagy and Mitophagy Compromising Cell Viability in Pluripotent Cell Model of Mitochondrial Disease.
Lin DS; Huang YW; Ho CS; Hung PL; Hsu MH; Wang TJ; Wu TY; Lee TH; Huang ZD; Chang PC; Chiang MF
Cells; 2019 Jan; 8(1):. PubMed ID: 30658448
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA Dynamics in Reprogramming to Pluripotency.
Sercel AJ; Carlson NM; Patananan AN; Teitell MA
Trends Cell Biol; 2021 Apr; 31(4):311-323. PubMed ID: 33422359
[TBL] [Abstract][Full Text] [Related]
17. Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.
Desquiret-Dumas V; Gueguen N; Barth M; Chevrollier A; Hancock S; Wallace DC; Amati-Bonneau P; Henrion D; Bonneau D; Reynier P; Procaccio V
Biochim Biophys Acta; 2012 Jun; 1822(6):1019-29. PubMed ID: 22306605
[TBL] [Abstract][Full Text] [Related]
18. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
[TBL] [Abstract][Full Text] [Related]
19. Neuropathological hallmarks in autopsied cases with mitochondrial diseases caused by the mitochondrial 3243A>G mutation.
Miyahara H; Tamai C; Inoue M; Sekiguchi K; Tahara D; Tahara N; Takeda K; Arafuka S; Moriyoshi H; Koizumi R; Akagi A; Riku Y; Sone J; Yoshida M; Ihara K; Iwasaki Y
Brain Pathol; 2023 Nov; 33(6):e13199. PubMed ID: 37534760
[TBL] [Abstract][Full Text] [Related]
20. Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutations.
Gramegna LL; Evangelisti S; Di Vito L; La Morgia C; Maresca A; Caporali L; Amore G; Talozzi L; Bianchini C; Testa C; Manners DN; Cortesi I; Valentino ML; Liguori R; Carelli V; Tonon C; Lodi R
Ann Clin Transl Neurol; 2021 Jun; 8(6):1200-1211. PubMed ID: 33951347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
